Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BARR

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 31
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 32
  • 0 comments

FDA approve NATEGLINIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 34
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

AKORN

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 117
  • 0 comments

FDA approve MIDAZOLAM HYDROCHLORIDE

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 30
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 32
  • 0 comments

FDA approve BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

Comment Full text

PAR PHARM

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 30
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 30
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 32
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Jan. 19, 2023, 12:38 UTC
  • 29
  • 0 comments

FDA approve DIAZEPAM

Comment Full text
  • Previous
  • 897
  • 898
  • 899
  • 900
  • 901
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243095)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin